Literature DB >> 3855540

Evidence that a second tumor antigen coded by adenovirus early gene region E1a is required for efficient cell transformation.

D R Hurwitz, G Chinnadurai.   

Abstract

The expression of the adenovirus (Ad) early coding region 1a (E1a) is required for virus-induced cell transformation and for the activation of other viral early genes and some cellular genes. Two overlapping early mRNAs of 13S and 12S that are transcribed from this region code for a 289-amino acid protein and a 243-amino acid protein, respectively. Earlier studies have shown that the 289-amino acid protein is essential for cell transformation. We have constructed an Ad type 2 (Ad2) deletion mutant (dl231) in which the intervening sequence for the 13S mRNA is precisely removed. Mutant dl231 is completely viable in human KB cells and produces normal amounts of 13S mRNA but much reduced amounts of a defective 12S mRNA. Mutant dl231 induces focal transformation of established rat embryo fibroblasts at a frequency one-fifth to one-half that of wild-type virus. However, the transformed cells are defective in their ability to form anchorage-independent colonies on semisolid medium. Therefore, our results demonstrate that the 243-amino acid protein is required for full transformation of rat embryo cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3855540      PMCID: PMC396992          DOI: 10.1073/pnas.82.1.163

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  Complex splicing patterns of RNAs from the early regions of adenovirus-2.

Authors:  L T Chow; T R Broker; J B Lewis
Journal:  J Mol Biol       Date:  1979-10-25       Impact factor: 5.469

2.  Structure of two spliced mRNAs from the transforming region of human subgroup C adenoviruses.

Authors:  M Perricaudet; G Akusjärvi; A Virtanen; U Pettersson
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

3.  Promoters and heterogeneous 5' termini of the messenger RNAs of adenovirus serotype 2.

Authors:  C C Baker; E B Ziff
Journal:  J Mol Biol       Date:  1981-06-25       Impact factor: 5.469

4.  Transformation-defective mutant of adenovirus type 5 containing a single altered E1a mRNA species.

Authors:  L R Carlock; N C Jones
Journal:  J Virol       Date:  1981-12       Impact factor: 5.103

5.  Control of messenger RNA concentration by differential cytoplasmic half-life. Adenovirus messenger RNAs from transcription units 1A and 1B.

Authors:  M C Wilson; J E Darnell
Journal:  J Mol Biol       Date:  1981-05-25       Impact factor: 5.469

6.  Transforming genes among three different oncogenic subgroups of human adenoviruses have similar replicative functions.

Authors:  J S Brusca; G Chinnadurai
Journal:  J Virol       Date:  1981-07       Impact factor: 5.103

7.  Transcriptional control in the production of liver-specific mRNAs.

Authors:  E Derman; K Krauter; L Walling; C Weinberger; M Ray; J E Darnell
Journal:  Cell       Date:  1981-03       Impact factor: 41.582

8.  Partial transformation of primary rat cells by the leftmost 4.5% fragment of adenovirus 5 DNA.

Authors:  A Houweling; P J van den Elsen; A J van der Eb
Journal:  Virology       Date:  1980-09       Impact factor: 3.616

9.  Regulation of integrated adenovirus sequences during adenovirus infection of transformed cells.

Authors:  D J Spector; D N Halbert; H J Raskas
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

10.  Isolation and partial characterization of the Drosophila alcohol dehydrogenase gene.

Authors:  D A Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

View more
  24 in total

1.  Identification of separate domains in the adenovirus E1A gene for immortalization activity and the activation of virus early genes.

Authors:  E Moran; B Zerler; T M Harrison; M B Mathews
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

2.  Adenovirus E1A coding sequences that enable ras and pmt oncogenes to transform cultured primary cells.

Authors:  B Zerler; B Moran; K Maruyama; J Moomaw; T Grodzicker; H E Ruley
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

3.  Lytic and transforming functions of individual products of the adenovirus E1A gene.

Authors:  E Moran; T Grodzicker; R J Roberts; M B Mathews; B Zerler
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

4.  An insertion mutation in the adenovirus type 12 early region 1A 13S mRNA unique region.

Authors:  K Ohshima; K Shiroki
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

5.  Adenovirus early region 1A protein increases the number of template molecules transcribed in cell-free extracts.

Authors:  K Leong; A J Berk
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

6.  Expression of adenovirus E1B mutant phenotypes is dependent on the host cell and on synthesis of E1A proteins.

Authors:  E White; B Stillman
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

7.  Different functional domains of the adenovirus E1A gene are involved in regulation of host cell cycle products.

Authors:  B Zerler; R J Roberts; M B Mathews; E Moran
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

8.  A retrovirus expressing the 12S adenoviral E1A gene product can immortalize epithelial cells from a broad range of rat tissues.

Authors:  R D Cone; T Grodzicker; M Jaramillo
Journal:  Mol Cell Biol       Date:  1988-03       Impact factor: 4.272

9.  Use of recombinant retroviruses to study the regulation of integrated adenovirus early promoters.

Authors:  R K Strair; J S Miller; B E Roberts
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

10.  Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation.

Authors:  V M Baragi; R R Renkiewicz; H Jordan; J Bonadio; J W Hartman; B J Roessler
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.